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BACKGROUND. The misclassification of race decreases the accuracy of cancer
incidence data for American Indians and Alaska Natives (AI/ANs) in some central
cancer registries. This article describes the data sources and methods that were
used to address this misclassification and to produce the cancer statistics used
by most of the articles in this supplement.
METHODS. Records from United States cancer registries were linked with Indian
Health Service (IHS) records to identify AI/AN cases that were misclassified as
non-AI/AN. Data were available from 47 registries that linked their data with IHS,
met quality criteria, and agreed to participate. Analyses focused on cases among
AI/AN residents in IHS Contract Health Service Delivery Area (CHSDA) counties
in 33 states. Cancer incidence and stage data were compiled for non-Hispanic
whites (NHWs) and AI/ANs across 6 IHS regions of the United States for 1999
through 2004.
RESULTS. Misclassification of AI/AN race as nonnative in central cancer registries
ranged from 85 individuals in Alaska (3.4%) to 5297 individuals in the Southern
Plains (44.5%). Cancer incidence rates among AI/ANs for all cancers combined
were lower than for NHWs, but incidence rates varied by geographic region for
AI/ANs. Restricting the rate calculations to CHSDA counties generally resulted in
higher rates than those obtained for all counties combined.
CONCLUSIONS. The classification of race for AI/AN cases in cancer registries can
be improved by linking records to the IHS and stratifying by CHSDA counties.
Cancer in the AI/AN population is clarified further by describing incidence rates
by geographic region. Improved cancer surveillance data for AI/AN communities
should aid in the planning, implementation, and evaluation of more effective
cancer control and should reduce health disparities in this population. Cancer
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A ccurate cancer surveillance data are essential toplan, implement, and evaluate cancer prevention
and control activities.1,2 The goal of producing reli-
able estimates of cancer occurrence in American
Indians and Alaska Native (AI/AN) populations has
been hampered by the misclassification of race that
frequently occurs in central cancer registries.3-8 Even
with such misclassification in many cancer registries,
data from New Mexico and Alaska9 and other
regions,5-8,10 as well as data from death records,11,12
indicate that wide regional variation in cancer bur-
den is characteristic of AI/AN populations. Clearly,
analyses that minimize misclassification of race have
the potential to provide to tribes and their cancer
control partners a more accurate description of the
cancer burden in AI/AN communities and, as a con-
sequence, the tools to plan and implement more
effective cancer prevention and control programs. In
this article, we describe methods used to mitigate
the effects of race misclassification and to produce
statistics on cancer incidence for individual regions,
for all regions combined, and for the AI/AN popula-
tion reported in the individual articles in this supple-
ment.
The 2004 intercensal population estimates of 3.1
million AI/AN individuals represented 1.1% of the
total United States population.13 These individuals
are members of—or related to—1 or more of over
560 federally recognized tribes or over 200 nonfeder-
ally recognized tribes, and they represent commu-
nities with diverse languages, cultures, and histories.
The median age of the United States AI/AN popula-
tion was just 29 years in 2000,14 far younger than the
nationwide median age of 38.6 years for non-His-
panic white (NHW) individuals (Fig. 1). Approxi-
mately 75% of the AI/AN population resides west of
the Mississippi River, and AI/ANs make up propor-
tionally greater percentages of the population in
Alaska, Oklahoma, and other selected regions—the
Southwest, the Northern Plains, and the Pacific
Northwest (Fig. 2). About 33% of AI/ANs reside on
tribal reservations, trust lands, or other tribally
affiliated areas; approximately 70% live in urban
areas.14,15
The Indian Health Service (IHS) provides pri-
mary healthcare to approximately 1.8 million en-
rolled members of federally recognized tribes, or
about 58% of the United States’ estimated 3.1 million
AI/AN population.16 The 150 IHS hospitals and
clinics are located primarily on reservation lands and
in a few cities with relatively large AI/AN popula-
tions. Half of these healthcare facilities are managed
by tribal governments under negotiated agreements
with the federal government, and half are operated
directly by the federal government. An additional 34
urban health centers receive some federal funding to
provide healthcare to the urban AI/AN population.
Eligible AI/ANs can receive healthcare at any IHS fa-
cility, but complex rules govern and restrict the deliv-
ery of contract health services for specialty medical
care, such as cancer treatment, which is generally
not available in IHS facilities. Funding for IHS is by
Congressional appropriation and is currently at the
level of $2532 per capita, far below the $5645 expen-
ditures per capita from all sources for personal medi-
cal services for the remaining United States
population.17
Central cancer registries generally determine AI/
AN ancestry on the basis of specific statements or
notations in the medical record. However, such infor-
mation is not always available and may be incorrect
or incomplete for mixed-race populations; significant
misclassification of AI/ANs as some other racial
FIGURE 1. These charts illustrate the population distribution of American
Indians and Alaska Natives (AI/AN) (top) and non-Hispanic whites (NHW)
(bottom) by age and sex in 2004 in the United States. Source: 2004 inter-
censal bridged single-race population estimates, U.S. Census Bureau/Centers
for Disease Control and Prevention/National Cancer Institute. Available at:
http://seer.cancer.gov/popdata/ Accessed on July 11,2008.
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group (nonnative) has been documented in central
cancer registries.3-8 These reports of misclassification
in central cancer registries have been derived from
linkages between registry records and patient regis-
tration records from the IHS. The use of such lin-
kages has been proposed as one mechanism for
correcting misclassification of AI/AN race in central
cancer registries in a timely manner and at relatively
low cost.18
MATERIALS AND METHODS
Cancer Cases
Central cancer registries receive case information
from multiple sources, including hospitals, outpati-
ent surgery centers, free-standing radiation centers,
and death certificates. In the United States, state and
metropolitan central cancer registries gather data on
cancer incidence. Two federal programs fund central
cancer registries: the National Program of Cancer
Registries (NPCR) of the Centers for Disease Control
and Prevention (CDC) and the Surveillance, Epidemi-
ology, and End Results (SEER) Program of the
National Cancer Institute (NCI). Together, NPCR and
SEER collect data for the entire United States popula-
tion (4 states—California, Kentucky, Louisiana, and
New Jersey—receive funding from both NPCR and
SEER).1
The SEER Program, which was established by the
NCI after Congress passed the National Cancer Act of
1971,19,20 currently collects cancer incidence and sur-
vival data from 17 population-based cancer registries
covering approximately 26% of the United States
population. Recognizing the need for more complete
geographic coverage for cancer incidence data, Con-
gress established the NPCR in 1992 by enacting the
Cancer Registries Amendment Act, Public Law 102-
515.21 Before establishment of the NPCR, 10 states
had no registry, and most states with registries lacked
the resources and legislative support they needed to
gather complete data. NPCR registries now cover
96% of the United States population. In 2001, NPCR
registries began annually reporting incidence data to
the CDC, with the first diagnosis year reported the
first year for which the registry collected data with
the assistance of NPCR funds. SEER and NPCR work
closely with the North American Association of Cen-
tral Cancer Registries (NAACCR) to develop and pro-
mote consensus standards for cancer registration,
provide education and training, certify population-
based registries, evaluate and publish data, and pro-
mote the use of cancer surveillance data.1
In this supplement, incidence data from the
registries refer to invasive cancers, with the exception
of the urinary bladder (bladder), which includes in
situ and invasive cancers,22,23 and breast cancer,
FIGURE 2. This map illustrates the percentage distribution of American Indian and Alaska Native population by county in 2004. Source: 2004 intercensal
bridged single-race population estimates, U.S. Census Bureau/Centers for Disease Control and Prevention/National Cancer Institute. Available at: http://seer.can-
cer.gov/popdata/ Accessed on July 11, 2008.
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which includes 1 tabulation with in situ cancers.24
Data on the primary cancer site and on histology
were coded according to the International Classifica-
tion of Diseases for Oncology (ICD-O) edition in use
at the time of diagnosis, converted to the 3rd edition
coding,25 then categorized according to SEER site
groups.26 Analysis by specific histologic diagnoses, in
addition to the SEER site groups, was included in
several articles (cancers of the lung, stomach, kidney
and urinary bladder).22,23,27-29
Geographic Coverage
Inclusion in the analytic dataset of data from indivi-
dual registries and for individual years was deter-
mined by several factors. First, registries had to meet
data standards developed for United States Cancer
Statistics1 for each year of data to be included. Five
state registries contributed data for fewer than the 6
years included in the analysis on this basis. Second,
3 states agreed to link their data with IHS yet
declined to include their data in the analytic dataset.
Finally, 1 state did not submit data in 2004 and was
excluded. Collectively, these last 4 states represented
2.2% of the AI/AN population estimates for 2004.
The ‘all counties’ incidence rates, for which no geo-
graphic restrictions apply, include data from 46 state
registries and the District of Columbia. For most
tabulations in this supplement, however, the analyses
were restricted to ‘Contract Health Service Delivery
Area’ (CHSDA) counties, which, in general, contain
federally recognized tribal lands or are adjacent to
tribal lands (Fig. 2). For incidence rates restricted to
CHSDA counties, data from 33 registries were
included.
CHSDA residence is used by the IHS to deter-
mine eligibility for services that are not available
directly within the IHS. Data from the IHS Division
of Epidemiology and Disease Prevention, using regis-
try records linked with the IHS patient registration
file, indicate less misclassification of race for AI/ANs
in these counties.30 The CHSDA counties also have
higher proportions of AI/ANs in relation to total
population than do non-CHSDA counties, with 56%
of the United States AI/AN population residing in the
624 counties designated as CHSDA (these counties
represent 20% of the 3141 counties in the United
States). Although less geographically representative
(Fig. 3), analyses restricted to CHSDA counties are
presented for cancer incidence in this report for the
purpose of offering improved accuracy in interpret-
ing cancer statistics for AI/ANs.
The analyses were completed for all regions
combined and by individual IHS regions: Alaska, Pa-
cific Coast, Northern Plains, Southern Plains, South-
west, and East (Fig. 3). Regional analyses have
been presented in several publications focusing on
FIGURE 3. This map shows the states and Contract Health Service Delivery Areas (CHSDA) counties by Indian Health Service region.
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AI/ANs,11,12,31,32 and it was determined that this
approach was preferable to the use of smaller juris-
dictions, such as the Administrative Areas defined by
IHS,33 which yielded less stable estimates. The geo-
graphic coverage of cancer registries and for resi-
dents in CHSDA counties by geographic regions is
shown in Table 1.
Classification of Race and Ethnicity
Current Office of Management and Budget standards
include the following minimum categories for the
collection of race information: AI/AN, Asian, black or
African American, Native Hawaiian or other Pacific
Islander, and white.34 These race categories represent
sociopolitical constructs and are not anthropologi-
cally or biologically based. The current standards
also allow census respondents to select 1 or more
races when they self-identify rather than a single
race as required in previous years.35 This allowance
for selection of multiple races has had a large impact
on the size of the total AI/AN population, evidenced
by the finding that the 2000 U.S. Census count for
those who reported their race as AI/AN either alone
or in combination with another race was over 58%
larger than the count of those who reported their
race as AI/AN alone.36
Here and in other articles included in this sup-
plement, cancer patients are classified as ‘American
Indian’ or ‘Alaska Native’ if they are identified as
such in the medical record (presumably by self-des-
ignation) or if they have sufficient native ancestry in
a federally recognized tribe to have received IHS ser-
vices. Individual tribes determine the degree of tribal
ancestry necessary for tribal membership, which, in
turn, determines eligibility to receive services from
IHS. To improve race classification for AI/AN cases
in contributing registries, state registries submitted
their case records diagnosed from as early as 1988 to
2004 for linkage with the IHS patient registration
database to identify AI/AN cases that were misclassi-
fied as nonnative. No clinical information was
released from the registries to the IHS. The records
of non-AI/ANs in the IHS database were removed
from the linkage database by applying an ‘Indian sta-
tus’ algorithm developed by the IHS that is based on
3 variables: beneficiary code, tribe, and blood quan-
tum (representing the proportion of native ancestry).
Linkages were conducted using LinkPlus, a probabil-
istic linkage software program that was developed by
the CDC for general application by cancer regis-
tries.37 By using key patient identifiers (ie, Social Se-
curity number, first name, last name, middle initial,
date of birth, and date of death), LinkPlus identifies
records that represent the same individual in the IHSTA
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and cancer registry databases. For each pair of
records, LinkPlus assigns a weight to each identifier;
these weights subsequently are combined into a final
weight, which is a large positive number if all or
most matching variables agree or a large negative
number if they disagree. Pairs with intermediate final
weights (designated as ‘clerical reviews’), were exam-
ined independently by 2 reviewers, who assigned a
status of match or nonmatch. Any discrepancies
between these 2 reviewers were adjudicated by a
third reviewer.
The race categories used by central cancer regis-
tries are specified in NAACCR standards and corre-
spond closely to the race categories used by the U.S.
Census Bureau to allow calculation of race-specific
incidence rates. Race is coded independent of Span-
ish/Hispanic origin.38 Beginning with cancer cases
diagnosed on January 1, 2000, registries have
reported data in up to 5 race fields for multiracial
individuals if that information is available from med-
ical records.34 Coding rules specify that, for indivi-
duals of multiple races, a nonwhite race takes
priority over white race for analytic purposes.39 For
this report, all cases classified as AI/AN in the first
race field were retained in that category. In addition,
when the first race field was classified as white or
unknown or ‘other’ and there was a positive IHS link,
the case also was reclassified as AI/AN for this
report. In contrast, if the first race field was coded as
Asian/Pacific Islander or black race and there was a
positive IHS link, then the value for the first race was
retained.39
Self-identification also provides the optimal
means to identify a individual’s Hispanic ethnicity,
but this information is not always found on cancer
records. In 2005, NAACCR published a standard
approach40 to strengthen the accuracy of Hispanic
ethnicity for cancer cases, and this approach was
used to identify NHW cases that were used as the
comparison group for rate ratios.
Population Estimates
Population estimates that are used as denominators
in the rate calculations are from the NCI’s publicly
available, web-based statistical resources and are the
same as those routinely included with the SEER*Stat
statistical analysis software.13 They are based on the
annual time series of July 1 estimates of county
populations by age, sex, race, and Hispanic origin
produced by the U.S. Census Bureau’s Population
Estimates Program.41
The Census Bureau currently develops annual
county-level population estimates for 31 possible
racial groups (5 single race groups and 26 multiple
race groups) to include individuals who select 1, 2, 3,
4, or all 5 of the race categories. Corresponding mul-
tiple-race information is not widely available, how-
ever, either from state vital records (mortality data)
or from medical records (incidence data). Therefore,
a method for bridging the multiple-race population
estimates to single-race estimates was developed by
the CDC’s National Center for Health Statistics using
information from the pooled 1997 through 2000
National Health Interview Surveys.36,42,43 These
bridged single-race estimates were used by the NCI
to produce the final population estimates that are
included in the calculations of incidence rates
appearing in this report.13 Development of the
bridged single-race data also makes the post-2000
race/ethnic population estimates comparable to the
pre-2000 race/ethnic estimates and enables the
reporting of a combined rate spanning 2000 as well
as trend analyses.
Statistical Methods
All rates, expressed per 100,000 population, were
directly age adjusted, using SEER*Stat software,44 to
the 2000 United States standard population (19 age
groups; Census P25-1130) in accordance with a 1998
U.S. Department of Health and Human Services rec-
ommendation.45,46 Readers should avoid comparison
of these data with published cancer rates that were
adjusted using a different standard population.
By using the age-adjusted incidence rates, stan-
dardized rate ratios (RRs) were calculated for AI/AN
populations using NHW rates for comparison. RRs
are calculated in SEER*Stat before rounding of rates
and may not equal RRs calculated by the reader
from rounded rates presented in the tables. Confi-
dence intervals (CIs) for age-adjusted rates and stan-
dardized RRs were calculated based on the methods
described by Tiwari et al47 using SEER*Stat version
6.3.6.44
Most of the articles in this supplement examined
the distribution of stage of disease at diagnosis for
AI/AN and NHW populations regionally and in all
regions combined. Incident cancer cases were classi-
fied as in situ, localized, regional, or distant using
SEER Summary Stage 1977 and/or Summary Stage
2000.48 If staging was not compatible between these
2 systems, then only cases diagnosed from 2001
through 2003 were included for statistics on cancer
stage.49 Relative percents (R percent) were calculated
by dividing the category-specific incidence rate by
the total rate to facilitate comparisons of the distri-
butions of age-adjusted, stage-specific incidence
rates between AI/AN and NHW populations across
IHS regions.
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RESULTS
Linkages with the IHS patient registration database
that were completed for 49 state cancer registries
and the District of Columbia are summarized by
region in Figure 4. In total, 12,103 AI/AN individuals
who had been classified as non-AI/AN were identi-
fied as AI/AN by the IHS linkage in these 49 states,
ranging from 85 individuals in the Alaska region
(3.4%) to 5297 individuals in the Southern Plains
region (44.5%).
For all regions combined, cancer incidence rates
for AI/ANs residing in CHDSA counties for all can-
cers combined were lower than for NHWs (AI/AN
men: RR, 0.75; AI/AN females: RR, 0.80; see Table 2),
but AI/AN incidence rates varied substantially by ge-
ographic region. These regional variations persisted
for most cancer sites among AI/ANs (data not
shown; see the Table of Contents of this supple-
ment), and incidence rates were significantly higher
among AI/ANs in Alaska and the Northern and
Southern Plains than among AI/ANs in the South-
west.
The effect of restricting calculations of incidence
rates to CHSDA counties generally resulted in higher
rates than were reported for all counties combined
(Table 2). For the Northern and Southern Plains, the
Pacific Coast, and the East, the rates with restriction
to CHSDA increased approximately 100 cases per
100,000 population per year. The rate changed less
for the Southwest region, where the CHSDA rate for
all cancers combined was 232.9 and that for all
counties combined was 221.0. Rates presented for ‘all
counties combined’ in Table 2 for Alaska were the
same as CHSDA county rates, because all counties in
that state are classified as CHSDA.
DISCUSSION
The methods used in this supplement enhance AI/
AN cancer surveillance by addressing race misclassi-
fication and by including analyses by geographic
region. Linkages of IHS and cancer registry data and
restricting analyses to CHSDA counties are efficient,
inexpensive ways of reducing AI/AN misclassification
and of improving the accuracy of cancer incidence
data among AI/ANs residing in CHSDA counties.
This supplement also includes data from 46 state
cancer registries, including 33 of the 35 states that
contain CHSDA counties, and, thus, is one of the
most comprehensive analyses of cancer incidence in
AI/AN populations to date.
Findings from the analyses reported here and in
other articles in this supplement, as well as earlier
reports from specific regions or registries,7,9,50-52 indi-
cate that wide regional variation is characteristic of
results from AI/AN cancer surveillance and that
region-specific data are essential to characterize the
AI/AN cancer burden. In general, cancer rates among
AI/ANs in CHSDA counties were highest in Alaska
and the Northern and Southern Plains and lowest in
the Southwest. In part, the wide regional variations
may reflect geographic variations in environmental,
social, and personal determinants of health (see the
article by Steele et al53 in this supplement). Research
designed to understand regional variations in disease
risk may help identify appropriate prevention and
control strategies.
Limitations
There are several limitations to consider when inter-
preting the results presented in this supplement.
First, although linkage with the IHS patient registra-
tion database improves the classification of race for
AI/AN cases, the issue is not resolved completely,
because AI/AN individuals who are not members of
the federally recognized tribes and are not eligible
for IHS services are not represented in the IHS data-
base. In addition, some individuals may be eligible
for, but never use, IHS services and, thus, are not
included in the IHS database. Second, the findings
from CHSDA counties highlighted in this supplement
do not represent all AI/AN populations in the United
States or in individual IHS regions (Table 1, Fig. 3).
In particular, the East region includes only 13.1% of
the total AI/AN population for that region. Further-
more, the analyses based on CHSDA designation
exclude many AI/AN residents in urban areas that
are not part of a CHSDA county. AI/AN residents of
urban areas differ from all AI/ANs in poverty level,
healthcare access, and other factors that may influ-
ence cancer trends.15,54 Third, this analysis revealed
FIGURE 4. This chart illustrates linkages with the Indian Health Service
(IHS) patient registration database that were completed for 49 state cancer
registries and the District of Columbia. AI/AN indicates American Indians and
Alaska Natives.
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less variation for NHWs than for AI/ANs by IHS
regions using data from CHSDA counties only. Per-
haps alternative groupings of states or counties
would reveal a different level of variation for NHWs.
Methods for Improving Cancer Surveillance Data
in AI/AN Populations
Cancer registrars rely on information available in
medical and administrative records for information
on race/ethnicity; often, this information either is
not available or is not collected and recorded in a
systematic manner. Several recent reports have
recommended that hospitals implement a uniform
framework for the collection of data on race, ethni-
city, and language, including a rationale for reporting
these data, the provision of scripts for employees to
use when interviewing patients, and the development
of other tools to facilitate data collection.55 Another
approach to improve race classification further for
AI/ANs is the development and expansion of tribal
rosters, such as the Northwest tribal roster,7 to com-
plement the IHS patient registration database and
thereby increase the usefulness of data linkages.
The high rate of misclassification of AI/AN race
on death certificates has been documented in several
studies.56,57 Although data on cancer mortality are
not presented in this supplement, data linkages
between IHS data and state death records are in pro-
gress to improve AI/AN mortality data in future
reports.
In conclusion, substantial progress has been
made in cancer surveillance in AI/AN populations to
provide a more comprehensive and accurate picture
of the cancer burden in this population than was
available previously. To build on this progress, the
cancer registry community and the many partners
who bring cancer surveillance to fruition should con-
tinue efforts to improve race classification and rou-
tine reporting of cancer in AI/AN populations. These
improved data should be readily available to the can-
cer control community to more effectively plan,
implement, and evaluate cancer control programs
that target AI/AN populations.
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